{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:37:32Z","timestamp":1768012652289,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,15]]},"DOI":"10.2146\/ajhp100516","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T21:42:12Z","timestamp":1304631732000},"page":"888-892","source":"Crossref","is-referenced-by-count":20,"title":["Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine"],"prefix":"10.1093","volume":"68","author":[{"given":"Hossein","family":"Khalili","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolreza","family":"Soudbakhsh","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita Hajhossein","family":"Talasaz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105535606200_b1-0680888","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.1840200215","article-title":"Renal duplex Doppler ultrasonography: a non-invasive predictor of kidney dysfunction and hepatorenal failure in liver disease","volume":"20","author":"Platt","year":"1994","journal-title":"Hepatology."},{"key":"key\n\t\t\t\t2019041105535606200_b2-0680888","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/hep.20832","article-title":"Hepatorenal syndrome: is it central hypovolemia, a cardiac disease, or part of gradually developing multiorgan dysfunction?","volume":"42","author":"Lenz","year":"2005","journal-title":"Hepatology."},{"key":"key\n\t\t\t\t2019041105535606200_b3-0680888","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Hani","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"key\n\t\t\t\t2019041105535606200_b4-0680888","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut."},{"key":"key\n\t\t\t\t2019041105535606200_b5-0680888","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/9780470691861","article-title":"Synthetic function","volume-title":"Textbook of hepatology: from basic science to clinical practice","author":"Rod\u00e9s","year":"2007","edition":"3rd ed"},{"key":"key\n\t\t\t\t2019041105535606200_b6-0680888","first-page":"407","article-title":"Bacterial infections in acute liver failure","volume-title":"Therapy in liver diseases","author":"Gimson","year":"1992"},{"key":"key\n\t\t\t\t2019041105535606200_b7-0680888","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(96)08054-3","article-title":"Fulminant hepatic failure","volume":"349","author":"Mas","year":"1997","journal-title":"Lancet."},{"key":"key\n\t\t\t\t2019041105535606200_b8-0680888","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0016-5085(03)01051-5","article-title":"Infection and the progression of hepatic encephalopathy in acute liver failure","volume":"125","author":"Vaquero","year":"2003","journal-title":"Gastroenterology."},{"key":"key\n\t\t\t\t2019041105535606200_b9-0680888","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1523-1755.1999.00252.x","article-title":"Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor","volume":"55","author":"Holt","year":"1999","journal-title":"Kidney Int."},{"key":"key\n\t\t\t\t2019041105535606200_b10-0680888","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet."},{"key":"key\n\t\t\t\t2019041105535606200_b11-0680888","first-page":"52","article-title":"Modifications of transaminases and blood bilirubin in viral hepatitis of the child treated with folinic acid","volume":"75","author":"Cocchi","year":"1965","journal-title":"Riv Clin Pediatr."},{"key":"key\n\t\t\t\t2019041105535606200_b12-0680888","first-page":"242","article-title":"Influence of folinic acid in the transaminases in viral hepatitis of the child","volume":"74","author":"Cocchi","year":"1964","journal-title":"Riv Clin Pediatr."},{"key":"key\n\t\t\t\t2019041105535606200_b13-0680888","first-page":"221","article-title":"[Acute hepatitis following administration of fansidar]. In German","volume":"120","author":"Meier","year":"1990","journal-title":"Schweiz Med Wochenschr."},{"key":"key\n\t\t\t\t2019041105535606200_b14-0680888","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM196710122771503","article-title":"Sulfonamide hepatic injury: review of the literature and report of a case due to sulfamethoxazole","volume":"277","author":"Dujovne","year":"1967","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041105535606200_b15-0680888","first-page":"1230","article-title":"Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole","volume":"89","author":"Altraif","year":"1994","journal-title":"Am J Gastroenterol."},{"key":"key\n\t\t\t\t2019041105535606200_b16-0680888","first-page":"167","article-title":"Trimethoprim-sulfamethoxazole- induced vanishing bile duct syndrome","volume":"92","author":"Yao","year":"1997","journal-title":"Am J Gastroenterol."},{"key":"key\n\t\t\t\t2019041105535606200_b17-0680888","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0016-5085(81)90146-3","article-title":"Terminal hepatic failure following a small dose of sulfa-methoxazole trimethoprim","volume":"80","author":"Ransohoff","year":"1981","journal-title":"Gastroenterology."},{"key":"key\n\t\t\t\t2019041105535606200_b18-0680888","first-page":"1577","article-title":"Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim","volume":"84","author":"Alberti-Flor","year":"1989","journal-title":"Am J Gastroenterol."},{"key":"key\n\t\t\t\t2019041105535606200_b19-0680888","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1967.03130230111028","article-title":"Granulomatous hepatitis associated with sulfadimethoxine hypersensitivity","volume":"202","author":"Espiritu","year":"1967","journal-title":"JAMA."},{"key":"key\n\t\t\t\t2019041105535606200_b20-0680888","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2009.02.008","article-title":"Drug-induced hepatotoxicity or drug-induced liver injury","volume":"13","author":"Pugh","year":"2009","journal-title":"Clin Liver Dis."},{"key":"key\n\t\t\t\t2019041105535606200_b21-0680888","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome","volume":"100","author":"Gordin","year":"1984","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041105535606200_b22-0680888","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2165\/00002018-199411030-00005","article-title":"Mechanisms of unpredictable adverse drug reactions","volume":"11","author":"Rieder","year":"1994","journal-title":"Drug Saf."},{"key":"key\n\t\t\t\t2019041105535606200_b23-0680888","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM196601132740209","article-title":"Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole","volume":"274","author":"Fries","year":"1966","journal-title":"N Engl J Med."},{"key":"key\n\t\t\t\t2019041105535606200_b24-0680888","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-102-5-722_1","article-title":"Fansidar and hepatic granulomas","volume":"102","author":"Lazar","year":"1985","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041105535606200_b25-0680888","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-106-3-393","article-title":"Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar)","volume":"106","author":"Zitelli","year":"1987","journal-title":"Ann Intern Med."},{"key":"key\n\t\t\t\t2019041105535606200_b26-0680888","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"key\n\t\t\t\t2019041105535606200_b27-0680888","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol."},{"key":"key\n\t\t\t\t2019041105535606200_b28-0680888","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2001.20645","article-title":"Comparison of two clinical scales for causality assessment in hepatotoxicity","volume":"33","author":"Lucena","year":"2001","journal-title":"Hepatology."},{"key":"key\n\t\t\t\t2019041105535606200_b29-0680888","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastro-enterology."},{"key":"key\n\t\t\t\t2019041105535606200_b30-0680888","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology."},{"key":"key\n\t\t\t\t2019041105535606200_b31-0680888","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1021763221337","article-title":"Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis","volume":"48","author":"Cassinello","year":"2003","journal-title":"Dig Dis Sci."},{"key":"key\n\t\t\t\t2019041105535606200_b32-0680888","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepatorenal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/10\/888\/28349358\/ajhp0888.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T15:26:18Z","timestamp":1560180378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/10\/888\/5129587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,15]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,5,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100516","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,5,15]]},"published":{"date-parts":[[2011,5,15]]}}}